Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed,
and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government
operating status and resumption of normal operations can be found at opm.gov.
The Management of Schizophrenia in Clinical Practice (MOSAIC)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
This study is a disease-based registry designed to follow patients with a DSM-IV-TR (Diagnostic and Statistic Manual of Mental Disorders, Text Revision) diagnosis of schizophrenia, schizoaffective disorder, or schizophreniform disorder treated in usual care settings for up to 5 years. The registry seeks to describe the course of disease in schizophrenia, including cognitive function and negative symptoms, its treatment, and its burden of disease for participants, caregivers, clinicians, and society as a whole.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients with schizophrenia, schizoaffective disorder, or schizophreniform across the disease spectrum treated in usual care settings
Adult patients, >/= 18 years of age
DSM-IV-TR diagnosis of schizophrenia, schizoaffective disorder, or schizophreniform disorder
Participants presenting with the normal course of care in usual treatment settings
Able to read and speak English
Able and willing to provide informed consent
Able and willing to comply with the study protocol
Participants enrolled as subjects in clinical trials at registry enrollment
Participants anticipating they will be unable to participate in regularly scheduled assessments as per protocol